良性前列腺增生病因及发病机制的研究现状(4)
[3]何雪梅.缓解良性前列腺增生的功能食品研究与开发[D].武汉：华中科技大学，2013.
[4]时浩清，孙立江.肥胖与良性前列腺增生[J].临床泌尿外科杂志，2015，30(1)：87-91.
[5]李莺，杨军，姚麒，等.良性前列腺增生临床进展与代谢综合征各成分的回归模型研究[J].中国医科大学学报，2013，42(5)：394-398.
[6]Ry A，Rotter I，Miazgowski T，et al.Metabolic syndrome and benign prostatic hyperplasia：association or coincidence？[J].Diabetology and metabolic syndrome，2015，29(7)：94.
[7]Hwang EC，Kim SO，Nam DH，et al.Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume[J].Low Urin Tract Symptoms，2015，7(1)：32-36.
, 百拇医药
[8]Hammarsten J，Hgstedt B.Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia[J].Eur Urol，2001，39(2)：151-158.
[9]Mc Connell JD，Roehrborn CG，Bautista OM，et al.The long-termeffectof doxazosin，finasteride，and combination therapy on the clinicalprogression of benign prostatic hyperplasia[J].N Engl J Med，2003，349(25)：2387-2398.
[10]Parsons JK，Carter HB，Partin AW，et al.Metabolic factors associated with benign prostatic hyperplasia[J].J Clin Endocrinol Metab，2006，91(7)：2562-2568.
, 百拇医药
[11]陈定雄，陈青青，李玉冰，前列腺增生患者合并代谢综合征的临床特点[J].中国老年学杂志，2010，30(14)：2065-2066.
[12]Nandeesha H，Koner BC，Dorairajan LN，et al.Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J].Clin Chim Acta，2006，370(1-2)：89-93.
[13]Ozden C，Ozdal OL，Urgancioglu G，et al.The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia[J].Eur Urol，2007，51(1)：199-203.
, http://www.100md.com
[14]Ploumidou K，Kyroudi-Voulgari A，Perea D，et al.Effect of a hypercholesterolemic diet on serum lipid profile，plasma sex steroid levels，and prostate structure in rats[J].Urology，2010，76(6)：1517.e1-5.
[15]Abclollah F，Briganti A，Suardi N，et al.Metabolic syndrome and benign prostatic hyperplasia：evidence of a potential relationship，hypothesized etiology，and prevention[J].Korean journal of urology，2011，52(8)：507-516.
[16]劉芳，杨小荣，刘焕兵，等.老年良性前列腺增生合并糖尿病患者的尿流动力学检测[J].中国老年学杂志，2016，36(2)：342-343.
, 百拇医药
[17]Xie LP，Bai Y，Zhang XZ，et al.Obesity and benign prostatic enlargement：a large observational study in China[J].Urology，2007，69(4)：680-684.
[18]Kristal AR，Arnold KB，Schenk JM，et al.Race/ethnicity，obesity，health related behaviors and the risk of symptomatic benign prostatic hyperplasia：results from the prostate cancer prevention trial[J].J Urol，2007，177(4)：1395-1400.
[19]Saito M，Tsounapi P，Oikawa R，et al.Prostatic ischemia induces ventral prostatic hyperplasia in the SHR；possible mechanism of development of BPH[J].Sci Rep，2014，4：3822., 百拇医药(任毅 王瑶 郑入文)
[4]时浩清，孙立江.肥胖与良性前列腺增生[J].临床泌尿外科杂志，2015，30(1)：87-91.
[5]李莺，杨军，姚麒，等.良性前列腺增生临床进展与代谢综合征各成分的回归模型研究[J].中国医科大学学报，2013，42(5)：394-398.
[6]Ry A，Rotter I，Miazgowski T，et al.Metabolic syndrome and benign prostatic hyperplasia：association or coincidence？[J].Diabetology and metabolic syndrome，2015，29(7)：94.
[7]Hwang EC，Kim SO，Nam DH，et al.Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume[J].Low Urin Tract Symptoms，2015，7(1)：32-36.
, 百拇医药
[8]Hammarsten J，Hgstedt B.Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia[J].Eur Urol，2001，39(2)：151-158.
[9]Mc Connell JD，Roehrborn CG，Bautista OM，et al.The long-termeffectof doxazosin，finasteride，and combination therapy on the clinicalprogression of benign prostatic hyperplasia[J].N Engl J Med，2003，349(25)：2387-2398.
[10]Parsons JK，Carter HB，Partin AW，et al.Metabolic factors associated with benign prostatic hyperplasia[J].J Clin Endocrinol Metab，2006，91(7)：2562-2568.
, 百拇医药
[11]陈定雄，陈青青，李玉冰，前列腺增生患者合并代谢综合征的临床特点[J].中国老年学杂志，2010，30(14)：2065-2066.
[12]Nandeesha H，Koner BC，Dorairajan LN，et al.Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J].Clin Chim Acta，2006，370(1-2)：89-93.
[13]Ozden C，Ozdal OL，Urgancioglu G，et al.The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia[J].Eur Urol，2007，51(1)：199-203.
, http://www.100md.com
[14]Ploumidou K，Kyroudi-Voulgari A，Perea D，et al.Effect of a hypercholesterolemic diet on serum lipid profile，plasma sex steroid levels，and prostate structure in rats[J].Urology，2010，76(6)：1517.e1-5.
[15]Abclollah F，Briganti A，Suardi N，et al.Metabolic syndrome and benign prostatic hyperplasia：evidence of a potential relationship，hypothesized etiology，and prevention[J].Korean journal of urology，2011，52(8)：507-516.
[16]劉芳，杨小荣，刘焕兵，等.老年良性前列腺增生合并糖尿病患者的尿流动力学检测[J].中国老年学杂志，2016，36(2)：342-343.
, 百拇医药
[17]Xie LP，Bai Y，Zhang XZ，et al.Obesity and benign prostatic enlargement：a large observational study in China[J].Urology，2007，69(4)：680-684.
[18]Kristal AR，Arnold KB，Schenk JM，et al.Race/ethnicity，obesity，health related behaviors and the risk of symptomatic benign prostatic hyperplasia：results from the prostate cancer prevention trial[J].J Urol，2007，177(4)：1395-1400.
[19]Saito M，Tsounapi P，Oikawa R，et al.Prostatic ischemia induces ventral prostatic hyperplasia in the SHR；possible mechanism of development of BPH[J].Sci Rep，2014，4：3822., 百拇医药(任毅 王瑶 郑入文)